In utero antiepileptic drug exposure: fetal death and malformations
about
Preconception counselling for women with epilepsy to reduce adverse pregnancy outcomePreconception counselling for women with epilepsy to reduce adverse pregnancy outcomeIntrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control studyCognitive function at 3 years of age after fetal exposure to antiepileptic drugsThe Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature ReviewPsychopharmacoteratophobia: Excessive fear of malformation associated with prescribing psychotropic drugs during pregnancy: An Indian perspectiveDrugs associated with teratogenic mechanisms. Part II: a literature review of the evidence on human risksStudying autism in rodent models: reconciling endophenotypes with comorbiditiesEURAP outcomes for seizure control during pregnancy: useful and encouraging data.Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled studyDifficulties in Treatment and Management of Epilepsy and Challenges in New Drug DevelopmentPrenatal exposure to lamotrigine: effects on postnatal development and behaviour in rat offspringPrenatal effects of antiepileptic drugs.Neural tube defects, folate, and immune modulation.Comparative safety of anti-epileptic drugs among infants and children exposed in utero or during breastfeeding: protocol for a systematic review and network meta-analysis.Testing the association between psychosocial job strain and adverse birth outcomes--design and methods.The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugsUse of antiepileptic drugs during pregnancy and risk of spontaneous abortion and stillbirth: population based cohort studyTeratogenic effects of antiepileptic drugsMonotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.Emerging drugs for epilepsy.Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges.Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest?Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended releaseA prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy.Antiepileptic drug use by pregnant women enrolled in Florida Medicaid.Prevalence of congenital anomalies in infants with in utero exposure to antiretroviralsWhen should we pay attention to unfavorable news from pregnancy registries?Teratogenicity of lamotriginePregnancy outcome of 149 pregnancies in women with epilepsy: Experience from a tertiary care hospital.Combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model.Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment SubcomDifferential effects of antiepileptic drugs on neonatal outcomes.Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis.Lamotrigine in breast milk and nursing infants: determination of exposure.2005 AES annual course: evidence used to treat women with epilepsy.Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.The adverse effects of antiepileptic drugs in children.Antiepileptic medication during pregnancy: does fetal genotype affect outcome?The continuing challenge of understanding, preventing, and treating neural tube defects.
P2860
Q24198152-2FC4175D-1CE4-42AA-905D-1B46DED61403Q24242734-BA466F0D-8895-4E9B-A8B8-292795EF99FBQ24631492-24FCF0F7-9FF9-41FB-8600-3337711E31FDQ24642570-FBCB438C-9657-4C8B-A47A-CD08ED406787Q26741366-B95F69A8-B9E4-4F60-8E19-D8315D5E0956Q26776321-19CCB5C0-9801-42FE-BDA0-4B24E6005058Q26991704-8E76FBD4-28E7-4724-BEF1-4AD4C1D9B68BQ30451745-5DC0D6D9-0F35-4ED2-8A3E-499D9D53BD6DQ33270669-34F4A262-DDDD-4076-A735-8EB2A869544AQ33665151-650FD3DE-77D2-4050-A268-5D110CE9F9F2Q33677979-D7FB2805-608B-4DA8-B169-02446AE15CD0Q33711330-62C7094F-2F42-4B76-B5D4-6B3B0EB94231Q33719069-F8120634-2EF4-4067-8608-989B4E476B68Q33739571-9018BC79-134C-4309-914B-1C2461C9BFE1Q33861432-90B14015-DDDC-4BBD-A815-37C0DAF81A19Q33879092-480362AB-16A0-40B9-BE76-0D1E65B42391Q33970119-1ED112FC-8D64-4A51-95C0-A80423B45D9AQ34077289-06D9E7C4-2495-4FCC-BFAA-ED99E90019D6Q34267151-47FFA965-0AFE-4C4C-8F3B-8DBB47C1325FQ34544208-FDC2849F-8B78-44A9-9171-A6ED02F8140BQ34688725-57D82645-5290-48C8-BE26-F60767B26220Q34823805-F9D6D76D-D9ED-494D-80BB-D38C2192DD5FQ34905287-6841EC5D-973F-499C-BF90-0CECE275FFA6Q34942400-6D8B67A2-90FC-49FB-81AA-EEE7637ED9F1Q35011452-CC36E16B-9953-4AE8-94F9-C80E2119B744Q35153696-9CF5BA20-52B5-4BE2-8848-B1859CD11375Q35680819-279E38D8-5187-4C24-AF79-C6F7D6E4FF8AQ35788481-03E03800-EDA0-4AE1-A459-8E3CCCBC91CFQ35942004-7A6B755A-7437-4019-8D86-BBB799F06A73Q36171808-D6EB92D7-06AF-45D2-8D7C-53B635D64BDBQ36243272-81AC2911-ECB9-4A74-82C9-6DF3910DE631Q36329558-BE6E1CD7-8CDD-4A86-BFA1-8492CE79A9EEQ36353155-6DC5232F-8FF1-4D98-A442-C39337E5DB41Q36354340-1C1512C9-8A2E-450C-8961-1D546591B70EQ36467106-72093E6C-7CF6-4E64-B06A-C36811CFA0AFQ36625015-8CCF5838-E871-4C30-A1C6-BC0653006D6DQ36660112-29D859AD-32D7-44ED-8A6A-F43761D2C888Q36811532-997B33EC-87A8-43A3-8E99-07C95D277CB4Q36863422-8E7FB472-56D0-4EEC-B259-06A733013761Q36914843-57528E06-506D-435B-800A-753E68E9FB33
P2860
In utero antiepileptic drug exposure: fetal death and malformations
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
In utero antiepileptic drug exposure: fetal death and malformations
@ast
In utero antiepileptic drug exposure: fetal death and malformations
@en
In utero antiepileptic drug exposure: fetal death and malformations
@nl
type
label
In utero antiepileptic drug exposure: fetal death and malformations
@ast
In utero antiepileptic drug exposure: fetal death and malformations
@en
In utero antiepileptic drug exposure: fetal death and malformations
@nl
prefLabel
In utero antiepileptic drug exposure: fetal death and malformations
@ast
In utero antiepileptic drug exposure: fetal death and malformations
@en
In utero antiepileptic drug exposure: fetal death and malformations
@nl
P2093
P2860
P1433
P1476
In utero antiepileptic drug exposure: fetal death and malformations
@en
P2093
D W Loring
J D Liporace
K J Meador
L A Kalayjian
NEAD Study Group
P B Pennell
P2860
P304
P356
10.1212/01.WNL.0000227919.81208.B2
P407
P577
2006-08-01T00:00:00Z